TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Call for new membership 2016–2018: Communities Delegation to Global Fund Board

Application deadline: Monday 9th November 2015 at 12:00hrs GMT
The Communities Delegation to the Global Fund Board represents communities living with HIV, and affected by TB and malaria at the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria. It has a voting seat.

Read More →

Call for new membership: Communities Delegation to UNITAID Board

Application deadline: 30th October 2015
The Communities Delegation to the UNITAID Board represents people living with and affected by HIV, TB and malaria and those co-infected with HIV and HCV, at the UNITAID Board and Committee level.

Read More →

Brazil, China, India and South Africa offer big opportunities for TB diagnostics

A new report from FIND, McGill International TB Centre, and UNITAID, entitled “TB Diagnostics Market in Select High-Burden Countries: Current Market and Future Opportunities for Novel Diagnostics”, notes that there is already a sizeable TB diagnostic market in these four countries.

Read More →

UNITAID report reviews new TB diagnostics and calls for more innovation

The updated edition of the UNITAID Tuberculosis Diagnostics Technology and Market Landscape report reviews current and potential technologies and critical market challenges to improved access to better TB diagnostics.

Read More →

Leave no one behind: First ever global meeting of TB patients and key affected populations

The Stop TB Partnership is convening the first ever global meeting of TB patients and key affected populations on 2nd and 3rd - 5th November in Bangkok, Thailand.

Read More →

Deadline extended until 30 October: Call for applications for the Stop TB Partnership's Challenge Facility for Civil Society Round 7

The Challenge Facility for Civil Society provides grants to technically sound and innovative interventions to support the engagement of communities in national tuberculosis responses.

Read More →

The 21st Century Cures Act’s “pathway to crisis” in drug safety

Federal legislation promises a substantial increase in NIH funding — at the expense of a significantly weakened FDA.

Read More →

The FDA’s concession conundrum

Can regulatory incentives promote responsible TB drug development?

Read More →

Improving regulatory systems to address global TB drug access failures

Worldwide inefficiencies in drug approval processes are proving disastrous for people living with TB and other diseases.

Read More →

Health officials urge action against TB and diabetes

Bali summit marks first major effort to mount defense against looming co-epidemic. 

Read More →

Page 73 of 133 · Total posts: 10

←First 72 73 74 Last→